-Blocker therapy in heart failure reviewed

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1327, 2002-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The addition of a β-blocker to regular ACE inhibitor therapy improves functional status in patients with chronic heart failure

Inpharma, Vol. 1, Iss. 1558, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Which Beta-Blocker is Most Effective in Heart Failure?

By Remme Willem

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 351-358

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic Therapy of Heart Failure

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2582-2591

Bentham Science Publishers

Access to resources Recommend Favorite

Frequency of compound genotypes associated with ββ-blocker efficacy in congestive heart failure

By Lanfear David E Marsh Sharon Cresci Sharon Spertus John A McLeod Howard L

Pharmacogenomics, Vol. 5, Iss. 5, 2004-07 ,pp. : 553-558

Future Medicine

Access to resources Recommend Favorite

Pharmacologic Therapy of Chronic Heart Failure

By Hamad Eman Mather Paul J. Srinivasan Siva Rubin Sharon Whellan David J. Feldman Arthur M.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite